Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Prev Sci. 2017 Nov;18(8):955–963. doi: 10.1007/s11121-017-0827-8

Table 1.

Characteristics of Intervention Group Sample by Gender

Characteristics TOTAL N (%) or Mean (range) Females N (%) or Mean (range) Male N (%) or Mean (range) Gender Difference Chi-square/T-test
Gender 410 (100%) 197 (48%) 213 (52%) NA
Age at baseline 14.8 (11–20) 14.7 (11–20) 14.9 (12–19) T=−1.24 (p=0.20)
Double vs. Single orphan N=146 (35.6%) N=61 (31.0%) N=85 (39.9%) F=34.0 (p= ≤.001)**
SES at baseline 2.2 (1–5) 2.3 (1–5) 2.1 (1–5) T=2.63 (p=01)**
Ever Boarded vs Never Boarded N=155 (38%) N=61 (31%) N=94 (44%) F=7.34 (p=0.01)**
Total Terms in School 7.96 (0–9) 7.76 (0–9) 8.14 (0–9) T=−1.86 (p=0.06)
Attended all 9 terms vs < 9 N=298 (72.7%) N=134 (68%) N=164 (77%) F=5.04 (p=0.02)*
All Fees Paid Appropriately N=387 (94%) N=183 (92%) N=204 (95%) F=1.60 (p=0.21)
All Uniforms Received N=395 (96%) N=190 (96%) N=205 (96%) F=0.01 (p=0.91)
% of Nurse Visits 79% (22%– 100%) 77% (22%– 100%) 81% (44%– 100%) T=−2.91 (p=0.004)**
Surveyed at Final Data Collection N=372 (91%) N=172 (87%) N=200 (94%) F=3.34 (p=0.07)
New Combined HIV/HSV-2 Incidence at Final data collection N=111 (31.1%) N=61 (37.7%) N=50 (25.6%) F=5.57 (p=0.02)*
Baseline HIV/HSV-2 N=23 (5.6%) N=14 (7.1%) N=9 (4.2%) F=1.97 (p=0.16)
New HIV Incidence at Final data collection N=2 (0.5%) N=1 (0.6%) N=1 (0.5%) F=0.01 (p=0.92)
Baseline HIV N=5 (1.2%) N=2 (1.0%) N=3 (1.4%) F=0.21 (p=0.64)
New HSV-2 incidence at Final Data Collection N=110 (30.8%) N=60 (37%) N=50 (25.6%) F=5.07 (0.02)*
Baseline HSV-2 N=18 (4.4%) N=12 (6.1%) N=6 (2.8%) F=3.18 (p=0.07)
*

p<.05;

**

p<.01

SES–Socio-economic status, measured as self-reported meals/day

HIV–Human Immunodeficiency Virus

HSV–2 Herpes Simplex Virus Type 2